ALB and neoplasm: Non-tumour liver tissue from Albumin-Cre; p53FL/FL mice retained the molecular features observed at the conclusion of the CCl4 treatment regime, including prominent hypertrophy in remaining normal hepatocytes (Fig. 4B) and significantly reduced CYP2A5 expression (Fig. 4B, E).